AKT1 and cancer: Zhao et al. reported that liraglutide inhibited cancer growth and metastasis and increased apoptosis in human pancreatic cancer cell lines and a mouse xenograft model via the inhibition of PI3K/AKT and ERK1/2 signaling pathways [54].